Bristol-Myers
Squibb Company (NYSE:BMY) will hold an investor event on Monday,
June 4, 2018 at 8:30 p.m. EDT (7:30 p.m. CDT) to discuss data presented
at the American Society of Clinical Oncology (ASCO) in Chicago. Company
executives will provide an overview of data presented from the company’s
oncology portfolio, and address questions from investors and analysts.
Investors and the general public are invited to listen to a live webcast
of the event at investor.bms.com.
Materials related to the event will be available at the same website
prior to the event. A replay of the event will be available and can be
accessed at investor.bms.com.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission
is to discover, develop and deliver innovative medicines that help
patients prevail over serious diseases. For more information about
Bristol-Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, Twitter,
YouTube
and Facebook.
Bristol-Myers Squibb Company Media: Ken Dominski, 609-252-5251 ken.dominski@bms.com orLisa McCormick Lavery, 609-252-7602 lisa.mccormicklavery@bms.com or Investors: Tim Power, 609-252-7509 timothy.power@bms.com orBill Szablewski, 609-252-5894 william.szablewski@bms.com